Noninvasive serial evaluation of myocardial mechanics in pressure overload hypertrophy of rabbit myocardium - PubMed (original) (raw)
Noninvasive serial evaluation of myocardial mechanics in pressure overload hypertrophy of rabbit myocardium
Adrian M Moran et al. Herz. 2003 Feb.
Abstract
Background: The determination of progression from afterload mismatch to myocardial failure in small animals requires invasive monitoring to assess ventricular pressure.
Objective: We sought to (1) validate the noninvasive determination of blood pressure using optical plethysmography, and (2) determine the time course and progression from afterload mismatch to myocyte failure in neonatal rabbits with coarctation (aortic banding at 7-10 days of life) compared to normal rabbits.
Methods and results: Comparison of continuous arterial pressure determined by optical plethysmography with high-fidelity intraarterial recording was performed in nine animals. An accuracy of 5.9 +/- 4.7 and 9.2 +/- 6.9 mm Hg for systolic and diastolic blood pressure was noted. Fourier analysis confirmed similar frequency components. Simultaneous transthoracic echocardiography and optical plethysmography were serially performed in 33 banded and 13 control animals. Load-dependent and -independent measures of myocardial function were obtained. Midwall contractility, initially normal, showed a gradual significant deterioration (0.22 +/- 1.68 [week 3] to -1.36 +/- 1.24 [week 6]; Z-scores).
Conclusions: This novel noninvasive method for determination of myocardial mechanics allows for serial evaluation of cardiac function and the determination of the time course from compensated hypertrophy to myocyte failure.
Similar articles
- Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M, Machida N, Mitsuishi M, Yamane Y. Kobayashi M, et al. Am J Hypertens. 2004 Dec;17(12 Pt 1):1112-9. doi: 10.1016/j.amjhyper.2004.07.007. Am J Hypertens. 2004. PMID: 15607617 - Noninvasive estimation of the end systolic pressure-volume relationship using impedance cardiography.
Summers RL. Summers RL. J Miss State Med Assoc. 2000 May;41(5):575-8. J Miss State Med Assoc. 2000. PMID: 10932520 - K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S, Long CL, Wang RH, Wang H. Gao S, et al. Cardiovasc Res. 2009 Aug 1;83(3):444-56. doi: 10.1093/cvr/cvp099. Epub 2009 Mar 20. Cardiovasc Res. 2009. PMID: 19304734 - Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy.
Tozzi R, Palladini G, Fallarini S, Nano R, Gatti C, Presotto C, Schiavone A, Micheletti R, Ferrari P, Fogari R, Perlini S. Tozzi R, et al. Am J Hypertens. 2007 Jun;20(6):663-9. doi: 10.1016/j.amjhyper.2007.01.016. Am J Hypertens. 2007. PMID: 17531925 - Changes in structure and function of the left ventricle in the hypertension syndrome.
Papademetriou V, Kokkinos PF. Papademetriou V, et al. J Cardiovasc Risk. 1997 Aug;4(4):261-5. J Cardiovasc Risk. 1997. PMID: 9477203 Review. No abstract available.
Cited by
- Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Barillas R, Friehs I, Cao-Danh H, Martinez JF, del Nido PJ. Barillas R, et al. Ann Thorac Surg. 2007 Jul;84(1):126-33. doi: 10.1016/j.athoracsur.2007.02.015. Ann Thorac Surg. 2007. PMID: 17588398 Free PMC article. - Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
Friehs I, Margossian RE, Moran AM, Cao-Danh H, Moses MA, del Nido PJ. Friehs I, et al. Basic Res Cardiol. 2006 May;101(3):204-13. doi: 10.1007/s00395-005-0581-0. Epub 2005 Dec 23. Basic Res Cardiol. 2006. PMID: 16369727 Free PMC article. - Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte death.
Yoshida T, Friehs I, Mummidi S, del Nido PJ, Addulnour-Nakhoul S, Delafontaine P, Valente AJ, Chandrasekar B. Yoshida T, et al. J Mol Cell Cardiol. 2014 Oct;75:141-51. doi: 10.1016/j.yjmcc.2014.07.007. Epub 2014 Aug 7. J Mol Cell Cardiol. 2014. PMID: 25108227 Free PMC article. - Vascular Endothelial Growth Factor Prevents Endothelial-to-Mesenchymal Transition in Hypertrophy.
Illigens BM, Casar Berazaluce A, Poutias D, Gasser R, Del Nido PJ, Friehs I. Illigens BM, et al. Ann Thorac Surg. 2017 Sep;104(3):932-939. doi: 10.1016/j.athoracsur.2017.01.112. Epub 2017 May 5. Ann Thorac Surg. 2017. PMID: 28483153 Free PMC article. - Endogenous angiogenesis inhibitors prevent adaptive capillary growth in left ventricular pressure overload hypertrophy.
Nikolova A, Ablasser K, Wyler von Ballmoos MC, Poutias D, Kaza E, McGowan FX, Moses MA, Del Nido PJ, Friehs I. Nikolova A, et al. Ann Thorac Surg. 2012 Nov;94(5):1509-17. doi: 10.1016/j.athoracsur.2012.05.052. Epub 2012 Jul 12. Ann Thorac Surg. 2012. PMID: 22795062 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical